Last Price
340.40
Today's Change
+0.225 (0.06%)
Day's Change
336.78 - 343.10
Trading Volume
314,109
Market Cap
10 Billion
Shares Outstanding
30 Million
Avg Volume
265,976
Avg Price (50 Days)
343.76
Avg Price (200 Days)
365.06
PE Ratio
27.26
EPS
12.62
Earnings Announcement
21-Apr-2025
Previous Close
340.77
Open
341.39
Day's Range
341.39 - 348.91
Year Range
302.01 - 459.77
Trading Volume
312,182
1 Day Change
0.94%
5 Day Change
0.36%
1 Month Change
1.96%
3 Month Change
9.21%
6 Month Change
-12.26%
Ytd Change
2.75%
1 Year Change
-10.46%
3 Year Change
145.63%
5 Year Change
242.93%
10 Year Change
1137.71%
Max Change
1137.71%
No result.
Sector: Healthcare - Healthcare
Industry: Diagnostics & Research
Description:
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.